TrademarkDir
TREELINE BIOSCIENCES
LIVE

Serial Number

90981524

Owner

Treeline Biosciences, Inc.

Attorney

Caitlin R. Byczko

First Use Date

Dec 27, 2024

Filing Date

Apr 22, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TREELINE BIOSCIENCES Trademark

Serial Number: 90981524 • Registration: 8042862

TREELINE BIOSCIENCES is a trademark filed by Treeline Biosciences, Inc. on April 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Treeline Biosciences, Inc. (8 trademarks)

Stamford, CT 06901

Entity Type: 03

Trademark Details

Filing Date

April 22, 2021

Registration Date

November 25, 2025

First Use Anywhere

December 27, 2024

First Use in Commerce

December 27, 2024

Published for Opposition

March 21, 2023

Goods & Services

pharmaceutical research and development in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; medical, pharmaceutical, and scientific research in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; medical, pharmaceutical, and scientific research in the field of biomarkers for use in diagnosing, preventing, and treating diseases and disorders, namely cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; clinical research and testing services not for medical diagnostic purposes in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials for use in diagnosing, preventing, and treating diseases and disorders, namely cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders

pharmaceutical products, namely, preparations for the prevention and treatment of cancer, lymphomas

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 25, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 6, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 6, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 31, 2025 SUPC
DIVISIONAL PROCESSING COMPLETE
Oct 31, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 30, 2025 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 21, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 20, 2025 EX4G
USE AMENDMENT FILED
May 16, 2025 IUAF
SOU TEAS EXTENSION RECEIVED
May 16, 2025 EEXT
SOU EXTENSION 4 FILED
May 15, 2025 EXT4
DIVISIONAL REQUEST RECEIVED
Jan 17, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jan 17, 2025 ERTD
TEAS STATEMENT OF USE RECEIVED
Jan 17, 2025 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 14, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 14, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 14, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 11, 2024 EXRA
SOU EXTENSION 3 GRANTED
Dec 11, 2024 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 9, 2024 AITU
SOU EXTENSION 3 FILED
Nov 12, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 12, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 6, 2024 EX2G
SOU EXTENSION 2 FILED
May 6, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 6, 2024 EEXT
ASSIGNED TO EXAMINER
Jan 12, 2024 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 5, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 3, 2023 EX1G
SOU EXTENSION 1 FILED
Oct 3, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 3, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 16, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 8, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 10, 2022 GNFN
FINAL REFUSAL E-MAILED
Aug 10, 2022 GNFR
FINAL REFUSAL WRITTEN
Aug 10, 2022 CNFR
ASSIGNED TO EXAMINER
Jul 14, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 22, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 22, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 22, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 20, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 20, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 20, 2021 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2021 NWOS
NEW APPLICATION ENTERED
Apr 26, 2021 NWAP

Related Trademarks

More from this Owner

TRLN

TRLN

TREELINE BIOSCIENCES

TREELINE BIOSCIENCES

TREELINEBIO

TREELINEBIO

TREELINEBIO

TREELINEBIO

Trademark logo

Serial #99359889

Trademark logo

Serial #99359889